Ingredient

Cocamide DEA

Cocamide DEA is flagged for pregnancy, trying to conceive, breastfeeding, postpartum, PCOS and general use. The concern behind the strongest flag is absorbed into the body and carcinogen concern.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
6 of 6
Counting avoid, high risk and medium risk
Irritancy
3 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Cocamide DEA and pregnancy

Not Recommended

Cocamide DEA is a surfactant derived from coconut oil and diethanolamine (DEA), used in cleansing products to create foam and increase product thickness. It is commonly found in shampoos, body washes, and facial cleansers to improve their cleaning and foaming properties. The primary concern during pregnancy relates to DEA's classification as a possible carcinogen and its potential for systemic absorption. According to the International Agency for Research on Cancer (IARC), DEA and DEA-related ingredients are classified as Group 2B (possibly carcinogenic to humans). Animal studies have shown that DEA can be absorbed through skin and has been linked to developmental effects including reduced fetal growth and skeletal abnormalities in offspring when pregnant animals were exposed. While these were high-dose studies, the potential for developmental toxicity raises concerns about use during pregnancy, particularly in the first trimester when fetal organs are forming. While there is no absolute prohibition from ACOG specifically naming Cocamide DEA, the general medical recommendation is to minimize exposure to potential carcinogens and developmental toxicants during pregnancy. Many obstetricians and dermatologists recommend pregnant women choose DEA-free alternatives given the documented concerns and the availability of safer surfactants. The precautionary approach is particularly warranted given that DEA can also form carcinogenic nitrosamines when combined with certain other cosmetic ingredients.

BreastfeedingCAUTION

Cocamide DEA and breastfeeding

Caution Advised

During breastfeeding, concerns about Cocamide DEA center on its potential for systemic absorption and theoretical transfer to breast milk, as well as possible carcinogenic properties. While specific data on DEA transfer to breast milk is limited, DEA can be absorbed through skin and has been detected in body tissues in animal studies. The AAD and lactation experts generally recommend that breastfeeding mothers avoid products with DEA-related ingredients when possible, particularly for leave-on products or those applied near the breast area. For rinse-off products used on areas away from the breastfeeding zone, the risk is lower but still present due to systemic absorption potential. Given the availability of safer surfactant alternatives and the concerns about carcinogenicity and potential infant exposure, many healthcare providers suggest choosing DEA-free personal care products during breastfeeding. The conservative approach is warranted when safer, effective alternatives are readily available.

PostpartumCAUTION

Cocamide DEA and postpartum

Caution Advised

For postpartum women not breastfeeding, the concerns about Cocamide DEA are primarily related to its classification as a possible carcinogen and its irritation potential. Postpartum skin can be more sensitive due to hormonal changes, potentially increasing susceptibility to irritation from this ingredient. While the immediate risks are lower than during pregnancy or breastfeeding, the long-term carcinogenic concerns remain. Many dermatologists recommend choosing products with safer surfactant alternatives regardless of reproductive status, given that DEA-free options are widely available and often gentler on skin.

Trying to ConceiveAVOID

Cocamide DEA and trying to conceive

Not Recommended

Women trying to conceive should follow pregnancy precautions for Cocamide DEA, as the developmental concerns identified in animal studies suggest potential risks that would be present from the moment of conception. The preconception period is an important time to minimize exposure to potential reproductive toxicants. Given DEA's systemic absorption and the animal evidence of developmental effects, fertility specialists often recommend discontinuing use of DEA-containing products when actively trying to conceive. This precautionary approach helps ensure that no exposure occurs during the critical early weeks of pregnancy before a woman may know she is pregnant.

PCOSCAUTION

Cocamide DEA and PCOS

Caution Advised

For women with PCOS, Cocamide DEA presents concerns beyond standard irritation risks. Some research suggests DEA may have weak estrogenic activity and could potentially interfere with hormonal balance, though evidence is limited. Women with PCOS, who already experience hormonal imbalances, may want to minimize exposure to ingredients with any endocrine activity. Additionally, women with PCOS often have more sensitive, acne-prone skin, and Cocamide DEA's moderate comedogenicity (pore-clogging potential) and irritation risk could exacerbate skin issues. The ingredient's surfactant properties can strip skin of natural oils, potentially triggering reactive oil production. Given the combination of potential hormonal effects, carcinogenic concerns, and skin irritation risks, dermatologists and endocrinologists often recommend women with PCOS choose gentler, DEA-free cleansing products. Safer surfactant alternatives are readily available and better suited for managing PCOS-related skin concerns.

General UseCAUTION

Cocamide DEA and general use

Caution Advised

For the general population, Cocamide DEA carries several documented concerns that have led many consumers and manufacturers to seek alternatives. The IARC classification as a possible human carcinogen (Group 2B) is based on animal studies showing increased tumor incidence with chronic exposure. While these were high-dose studies, the potential cancer risk has prompted California to require warning labels on products containing DEA under Proposition 65. Beyond cancer concerns, Cocamide DEA is a known skin irritant and can cause allergic contact dermatitis in sensitive individuals. The ingredient can also react with other cosmetic ingredients (particularly nitrosating agents) to form carcinogenic nitrosamines, which is why the EU requires manufacturers to prevent nitrosamine formation in products containing DEA-related compounds. Due to these well-documented concerns, many cosmetic manufacturers have reformulated to remove DEA and DEA-related ingredients, replacing them with safer surfactants like cocamidopropyl betaine or glucoside-based cleaners. Consumers seeking to minimize exposure to potential carcinogens are advised to choose DEA-free products, which are now widely available across all price points.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store